Back to Search
KAELA MILLER, MD
MD
Gastroenterology Physician
NPI: 1457939381Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
PMID 18160686·N Engl J Med·2007
3-trial
A physiologic imaging pilot study of breast cancer treated with AZD2171.
PMID 16397053·Clin Cancer Res·2006
7-preclinical
A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer.
PMID 15867237·Clin Cancer Res·2005
3-trial
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.
PMID 15692762·Breast Cancer Res Treat·2005
3-trial
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
PMID 15681523·J Clin Oncol·2005
3-trial
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
PMID 15041714·Clin Cancer Res·2004
3-trial
Breast cancer: the role of angiogenesis and antiangiogenic therapy.
PMID 15474336·Hematol Oncol Clin North Am·2004
6-review
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
PMID 15084233·Breast Cancer Res·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 702 ROTARY CIR STE 225
INDIANAPOLIS, IN 46202 - Phone
- (317) 278-4427
Quick Facts
- NPI
- 1457939381
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile